Medical/Pharmaceuticals
Say NO to Food Allergies, Taiwan User-Friendly Sensor & Tech (TFT) Creates Personalized Food Allergen Detection System
LAS VEGAS, Jan. 10, 2020 /PRNewswire/ -- Taiwan User-Friendly Sensor and Tech
(TFT) and other notable homegrown startups led by Taiwan Tech Arena (TTA) are
now showcasing their innovative solutions at CES 2020.
2020-01-11 00:00
1803
Seneca Biopharma Announces Presentations at Both Sachs Associates 3rd Annual Neuroscience Innovation Forum & Biotech Showcase™ 2020
GERMANTOWN, Maryland, Jan. 10, 2020 /PRNewswire/ -- Seneca Biopharma, Inc., (NASDAQ: SNCA), a clinical-stage biopharmaceutical company developing novel treatments for diseases of unmet medical need, announced today thatSeneca's Executive Chairman,Ken Carter, will present at both Sachs Associates ...
2020-01-11 00:00
6631
GCAM Adds New Plasma Collection Center
FULLERTON, Calif. and YONGIN, South Korea, Jan. 10, 2020 /PRNewswire/ -- GCAM, Inc., a U.S. based plasma collection company, announced that it has added additional plasma collection centers; located inEdinburg, Texas. With the newest additions, GCAM now runs 12 plasma donation centers nationwide....
2020-01-10 22:00
1758
VolitionRx Completes Acquisition of Octamer GmbH
AUSTIN, Texas, Jan. 10, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced the closing of the acquisition of the epigenetic reagent company Octamer GmbH ("Octamer") by its subsidiary Belgian Volition SPRL for approximately$725,000, consisting of cash and sh...
2020-01-10 21:00
15245
VISTA Eye Specialist bringing vision correction to a whole breakthrough level of safety
KUALA LUMPUR, Malaysia, Jan. 10, 2020 /PRNewswire/ -- VISTA Eye Specialist (VISTA), one of the premier and largest eye specialist inMalaysia, announces the introduction of No-Blade ICL, a combination of the Ziemer LDV Z8 Femtosecond Laser and the Visian EVO ICL. Placed within the eye, the ICL hel...
2020-01-10 17:32
3683
Cala Health Applauded by Frost & Sullivan for Revolutionizing the Essential Tremor Market with its Body-worn Neuromodulation Therapy, Cala Trio(TM)
SANTA CLARA, Calif., Jan. 9, 2020 /PRNewswire/ -- Based on its recent analysis of the North American essential tremor (ET) treatment market, Frost & Sullivan recognizes Cala Health, Inc. with the 2019 North American Technology Innovation Award for its Cala Trio™, a prescription-only, wrist-worn d...
2020-01-09 22:00
1022
WuXi Biologics and Almirall Sign Strategic Collaboration Agreement for Multiple Bispecific Antibodies Targeting Dermatology Diseases
* The 12th global licensing partnership for WuXiBody™ since its launch in August 2018 showcasing the power and versatile applications of WuXiBody™ in multiple therapeutic areas SHANGHAI and BARCELONA, Spain, Jan. 9, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global o...
2020-01-09 17:10
2635
Alma, a Sisram Medical Company, Launches DermaClear 3-in-1 Skin Hydradermabrasion Platform
NUREMBERG, Germany, Jan. 9, 2020 /PRNewswire/ -- Alma, one of the top five global leaders of energy-based medical and aesthetic solutions, today announced the launch of DermaClear, a powerful 3-in-1 treatment solution for deep cleansing, nourishment, and hydration of facial skin. DermaClear i...
2020-01-09 17:00
1690
Alma, a Sisram Medical Company, Receives Excellence Award for "Outstanding Business Performance in Japan"
NURNBERG, Germany, Jan. 9, 2020 /PRNewswire/ -- Alma, one of the top five global leaders of energy-based medical and aesthetics solutions, today announced it has been recognized with an Excellence Award for its "outstanding business performance inJapan" in 2019. The annual "Excellence Award" was...
2020-01-09 10:00
1387
Daewoong Infion obtained World's First Halal Certification for Biopharmaceutical Product Derived from Animal Cells
SEOUL, South Korea, Jan. 9, 2020 /PRNewswire/ -- Daewoong Infion Co. has
achieved world's first halal certification for animal cells-derived
biopharmaceuticals.
2020-01-09 09:51
3372
Publication of a Toxicological Study: A Milestone for Jennewein Biotechnologie for the GRAS Approval of the HMO-mix
RHEINBREITBACH, Germany, Jan. 9, 2020 /PRNewswire/ -- Jennewein Biotechnology announces another milestone in the worldwide approval of a new product generation, the "HMO-Mix." The data of the toxicological study, with the title "A Safety Evaluation of Mixed Human Milk Oligosaccharides in Rats," w...
2020-01-09 02:26
2557
Symmetry Surgical, Inc. Acquires The O.R. Company
Acquisition strengthens Symmetry's commitment to deliver best-in-class, cost-effective solutions NASHVILLE, Tennessee, Jan. 9, 2020 /PRNewswire/ -- Symmetry Surgical, Inc. ("Symmetry"), is pleased to announce that it has completed its acquisition of The O.R. Company. The O.R. Company develops, m...
2020-01-09 00:37
1353
Waters Corporation Lauded by Frost & Sullivan for Developing the First Truly Smart Mass Spectrometer, the BioAccord LC-MS System
The system was designed to enhance productivity, positioning the user to acquire and process data with a purpose-built LC-MS platform SANTA CLARA, California, Jan. 8, 2020 /PRNewswire/ -- Based on its analysis of the global biopharmaceutical analytical instrumentation market, Frost & Sullivan ...
2020-01-08 21:30
6330
Transcenta Holding Secures $100 Million Series B Plus Financing
HONG KONG and SUZHOU and HANGZHOU, China, Jan. 8, 2020 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta"), a global biotherapeutics company with fully-integrated capabilities in discovery, R&D, and manufacturing of antibody-based therapeutics, announces today that it has sealed a 100 millio...
2020-01-08 21:00
1529
Former Celgene Chairman and CEO Mark J. Alles Joins Antengene Board of Directors
SHANGHAI and PHILADELPHIA, Jan. 8, 2020 /PRNewswire/ -- The Antengene board today announced the appointment of Mr.Mark J. Alles as an independent director of the company, effectiveJanuary 2, 2020. Mr. Alles is the former Chairman and Chief Executive Officer of Celgene Corporation, now a subsidiar...
2020-01-08 20:00
3186
Connect Biopharma Reports Positive Topline Data from Moderate-to-severe Atopic Dermatitis (AD) Phase 1b Study of CBP-201
Data show superior efficacy after four weeks of treatment and more rapid onset of action for CBP-201 compared with data from studies of current standard of care therapy for AD On Day 29, 42.9% and 50.0% of patients receiving CBP-201 300 mg or 150 mg, respectively, achieved "clear/almost clear" s...
2020-01-08 19:00
1053
CStone announces first patient dosed in the Phase III trial of CS1001 in combination with chemotherapy in first-line esophageal squamous cell carcinoma
SUZHOU, China, Jan. 8, 2020 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) announced that the first patient has been dosed in the Phase III GEMSTONE-304 study of the Company's anti-PD-L1 antibody CS1001 in combination therapy as first-line treatment in patients wit...
2020-01-08 13:45
3100
Daewoong Pharmaceutical Receives World's First Halal Certification for Biopharmaceutical Product Derived from Animal Cells through Indonesian Joint Venture, Daewoong Infion
SEOUL, South Korea, Jan. 8, 2020 /PRNewswire/ -- Daewoong Infion Co. has achieved world's first halal certification for animal cells-derived biopharmaceuticals. Daewoong Pharmaceutical Co., Ltd. (CEO Sengho Jeon) announced that Daewoong Infion, the company's joint venture with Infion, an In...
2020-01-08 11:00
1378
Hummingbird Bioscience Publishes Preclinical Data Demonstrating Efficacy of HMBD-001 in HER3 Driven Cancers
* HER3 activation is implicated in tumor progression and in acquired resistance to EGFR and HER2 therapies * Study, published in Molecular Cancer Therapeutics, found HMBD-001 to be able to uniquely block HER3 dimerization interface and potently inhibit tumor growth SINGAPORE, Jan. 8, 2020 /PR...
2020-01-08 10:40
859
Rapid Diagnostics Announces Completion of Asset Purchase and New Corporate Strategies
LONDON, Jan. 8, 2020 /PRNewswire/ -- Rapid Diagnostics ML Limited, UK is pleased to announce the return of its Point of Care (PoC) platform, the MiniLab System. Rapid was formed to purchase the assets and Intellectual Property (IP) of the former Enigma Diagnostics, which was liquidated in 2017. ...
2020-01-08 08:00
2159
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
5902
